u-62840 and Intestinal-Perforation

u-62840 has been researched along with Intestinal-Perforation* in 1 studies

Other Studies

1 other study(ies) available for u-62840 and Intestinal-Perforation

Article	Year
Early failure of eculizumab in a patient with malignant atrophic papulosis: Is it time for initial combination therapy of eculizumab and treprostinil? The Journal of dermatology, 2020, Volume: 47, Issue:1 Topics: Adult; Antibodies, Monoclonal, Humanized; Anticoagulants; Cerebral Hemorrhage; Combined Modality Therapy; Complement Inactivating Agents; Epoprostenol; Fatal Outcome; Glucocorticoids; Humans; Intestinal Perforation; Male; Malignant Atrophic Papulosis; Prognosis; Prostaglandins, Synthetic; Treatment Outcome	2020

Article

Year

Early failure of eculizumab in a patient with malignant atrophic papulosis: Is it time for initial combination therapy of eculizumab and treprostinil?

The Journal of dermatology, 2020, Volume: 47, Issue:1

Topics: Adult; Antibodies, Monoclonal, Humanized; Anticoagulants; Cerebral Hemorrhage; Combined Modality Therapy; Complement Inactivating Agents; Epoprostenol; Fatal Outcome; Glucocorticoids; Humans; Intestinal Perforation; Male; Malignant Atrophic Papulosis; Prognosis; Prostaglandins, Synthetic; Treatment Outcome

2020